IL17RA antibody (AA 201-300)
Quick Overview for IL17RA antibody (AA 201-300) (ABIN747908)
Target
See all IL17RA AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- AA 201-300
-
Cross-Reactivity
- Human, Mouse
-
Predicted Reactivity
- Rat
-
Purification
- Purified by Protein A.
-
Immunogen
- KLH conjugated synthetic peptide derived from human IL17R
-
Isotype
- IgG
-
-
-
-
Application Notes
-
WB 1:300-5000
ELISA 1:500-1000
IHC-P 1:200-400
IHC-F 1:100-500
IF(IHC-P) 1:50-200
IF(IHC-F) 1:50-200
IF(ICC) 1:50-200 -
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 1 μg/μL
-
Buffer
- 0.01M TBS( pH 7.4) with 1 % BSA, 0.02 % Proclin300 and 50 % Glycerol.
-
Preservative
- ProClin
-
Precaution of Use
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
-
Storage
- 4 °C,-20 °C
-
Storage Comment
- Shipped at 4°C. Store at -20°C for one year. Avoid repeated freeze/thaw cycles.
-
Expiry Date
- 12 months
-
-
-
Identification of hub genes and pathways associated with bladder cancer based on co-expression network analysis." in: Oncology letters, Vol. 14, Issue 1, pp. 1115-1122, (2017) (PubMed).
: "Role of T helper 17 cytokines in the tumour immune inflammation response of patients with laryngeal squamous cell carcinoma." in: Oncology letters, Vol. 14, Issue 1, pp. 561-568, (2017) (PubMed).
: "
-
Identification of hub genes and pathways associated with bladder cancer based on co-expression network analysis." in: Oncology letters, Vol. 14, Issue 1, pp. 1115-1122, (2017) (PubMed).
-
- IL17RA (Interleukin 17 Receptor A (IL17RA))
-
Alternative Name
- IL17RA/CD217
-
Background
-
Synonyms: CD217, IL17R, CANDF5, CDw217, IL-17RA, hIL-17R, Interleukin-17 receptor A, IL-17 receptor A, IL17RA
Background: Receptor for IL17A, IL17F and, in dimer with IL17RE, for IL17C. Binds its IL17A ligand with low affinity, suggesting that additional components are involved in IL17A-induced signaling.
-
Gene ID
- 23765
-
UniProt
- Q96F46
-
Pathways
- SARS-CoV-2 Protein Interactome
Target
-